Vertex Pharmaceuticals Inc / Ma (VRTX) insider trading.
In Q3 2026, insiders at Vertex Pharmaceuticals Inc / Ma reported 8 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 3 sales worth $2.0M.
- Transactions
- 8
- Purchases (P)
- 0
- Sales (S)
- 3
- Net shares, P minus S
- -3,869
- Insiders
- 7
- Last filed
- 2026-09-10
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Tatsis Ourania | Officer · EVP, Chief Reg. & Quality Off. | 2 | 0 | 1 |
| van Grunsven Jasper | Officer · EVP, CP and NPPO | 1 | 0 | 0 |
| Ambrose Kristen | Officer · SVP & Chief Accounting Officer | 1 | 0 | 0 |
| Sachs Bruce I | Director | 1 | 0 | 0 |
| Sachdev Amit | Officer · EVP Chief Patient & Ext Af Off | 1 | 0 | 0 |
| McKechnie Duncan | Officer · EVP, Chief Commercial Officer | 1 | 0 | 1 |
| Liu Joy | Officer · EVP and Chief Legal Officer | 1 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-08 | van Grunsven Jasper | A (A) | 8,682 | $0 | 8,682 | Form 4 |
| 2026-08-28 | Ambrose Kristen | A (A) | 5,000 | $0 | 11,624 | Form 4 |
| 2026-08-27 | Sachs Bruce I | G (D) | 6,000 | $0 | 39,000 | Form 4 |
| 2026-07-21 | Sachdev Amit | A (A) | 8,251 | $0 | 66,512 | Form 4 |
| 2026-07-21 | Tatsis Ourania | A (A) | 8,251 | $0 | 53,572 | Form 4 |
| 2026-07-02 | McKechnie Duncan | S (D) | 1,541 | $519 | 11,001 | Form 4 |
| 2026-07-02 | Tatsis Ourania | S (D) | 1,500 | $524.99 | 45,321 | Form 4 |
| 2026-07-01 | Liu Joy | S (D) | 828 | $502.71 | 19,131 | Form 4 |
Transaction codes in this quarter
Get VRTX insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=875320&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · VRTX company page · Vertex Pharmaceuticals Inc / Ma on SEC.gov
Questions
Are insiders buying or selling Vertex Pharmaceuticals Inc / Ma (VRTX)?
In Q3 2026, insiders at Vertex Pharmaceuticals Inc / Ma reported 8 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 3 sales worth $2.0M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Vertex Pharmaceuticals Inc / Ma insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/vrtx.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.